InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the detailed record of transactions filed by Tardio Jason. Director active across 2 companies, notably Ovid Therapeutics Inc.. In total, 4 reports have been published. Breakdown: 2 buys · 1 sell. Total volume traded: €54k. History available since 12 September 2022. The latest transaction was filed on 5 June 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Jason Tardio is a declarant linked to Immunic, INC. and Ovid Therapeutics Inc., where he is listed as President and COO and Chief Operating Officer. The record shows 4 filings in total, and across the 4 most recent filings, the aggregated amounts show EUR 17,260 of buys and EUR 36,813 of sells, over the period from 2022-09-14 to 2025-06-20.